---
input_text: 'Long-Term Outcomes of Hypertrophic Cardiomyopathy Diagnosed During Childhood:
  Results From a National Population-Based Study. BACKGROUND: Late survival and symptomatic
  status of children with hypertrophic cardiomyopathy have not been well defined.
  We examined long-term outcomes for pediatric hypertrophic cardiomyopathy. METHODS:
  The National Australian Childhood Cardiomyopathy Study is a longitudinal population-based
  cohort study of children (0-10 years of age) diagnosed with cardiomyopathy between
  1987 and 1996. The primary study end point was time to death or cardiac transplantation.
  RESULTS: There were 80 patients with hypertrophic cardiomyopathy, with a median
  age at diagnosis of 0.48 (interquartile range, 0.1, 2.5) years. Freedom from death/transplantation
  was 86% (95% confidence interval [CI], 77.0-92.0) 1 year after presentation, 80%
  (95% CI, 69.0-87.0) at 10 years, and 78% (95% CI, 67.0-86.0) at 20 years. From multivariable
  analyses, risk factors for death/transplantation included symmetrical left ventricular
  hypertrophy at the time of diagnosis (hazard ratio, 4.20; 95% CI, 1.60-11.05; P=0.004),
  Noonan syndrome (hazard ratio, 2.88; 95% CI, 1.02-8.08; P=0.045), higher posterior
  wall thickness z score (hazard ratio, 1.45; 95% CI, 1.22-1.73; P<0.001), and lower
  fractional shortening z score (hazard ratio, 0.84; 95% CI, 0.74-0.95; P=0.005) during
  follow-up. Nineteen (23%) subjects underwent left ventricular myectomy. At a median
  of 15.7 years of follow-up, 27 (42%) of 63 survivors were treated with beta-blocker,
  and 13 (21%) had an implantable cardioverter-defibrillator. CONCLUSIONS: The highest
  risk of death or transplantation for children with hypertrophic cardiomyopathy is
  within 1 year after diagnosis, with low attrition rates thereafter. Many subjects
  receive medical, surgical, or device therapy.'
raw_completion_output: |-
  primary_disease: Hypertrophic Cardiomyopathy

  medical_actions: Left ventricular myectomy; Beta-blocker therapy; Implantation of implantable cardioverter-defibrillator

  symptoms: Symmetrical left ventricular hypertrophy; Higher posterior wall thickness z score; Lower fractional shortening z score

  chemicals: Beta-blocker

  action_annotation_relationships: Left ventricular myectomy TREATS symmetrical left ventricular hypertrophy IN Hypertrophic Cardiomyopathy; Beta-blocker therapy (with Beta-blocker) TREATS Hypertrophic Cardiomyopathy; Implantation of implantable cardioverter-defibrillator PREVENTS sudden cardiac death IN Hypertrophic Cardiomyopathy; Higher posterior wall thickness z score INCREASES RISK IN Hypertrophic Cardiomyopathy; Lower fractional shortening z score INCREASES RISK IN Hypertrophic Cardiomyopathy
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Lower fractional shortening z score INCREASES RISK IN Hypertrophic Cardiomyopathy

  ===

extracted_object:
  primary_disease: MONDO:0005045
  medical_actions:
    - Left ventricular myectomy
    - Beta-blocker therapy
    - Implantation of implantable cardioverter-defibrillator
  symptoms:
    - Symmetrical left ventricular hypertrophy
    - Higher posterior wall thickness z score
    - Lower fractional shortening z score
  chemicals:
    - CHEBI:35530
  action_annotation_relationships:
    - subject: Left ventricular myectomy
      predicate: TREATS
      object: symmetrical left ventricular hypertrophy
      qualifier: MONDO:0005045
    - subject: Beta-blocker therapy
      predicate: TREATS
      object: HP:0001639
      subject_qualifier: with Beta-blocker
      subject_extension: CHEBI:35530
    - subject: <Implantation of implantable cardioverter-defibrillator>
      predicate: <PREVENTS>
      object: <sudden cardiac death>
      qualifier: <Hypertrophic Cardiomyopathy>
      subject_qualifier: <Not applicable>
      object_qualifier: <Not applicable>
      subject_extension: <Not applicable>
      object_extension: <Not applicable>
    - subject: Higher posterior wall thickness z score
      predicate: INCREASES RISK IN
      qualifier: MONDO:0005045
    - subject: Lower fractional shortening z score
      predicate: INCREASES RISK IN
      qualifier: MONDO:0005045
named_entities:
  - id: CHEBI:33281
    label: antibiotics
  - id: MONDO:0006936
    label: pulmonary valve stenosis
  - id: MAXO:0009072
    label: surgical repair
  - id: HP:0001642
    label: pulmonary valve stenosis
  - id: MONDO:0018997
    label: Noonan syndrome
  - id: HP:0004322
    label: short stature
  - id: CHEBI:37845
    label: GH
  - id: MONDO:0011908
    label: Juvenile myelomonocytic leukemia (JMML)
  - id: MAXO:0000747
    label: hematopoietic stem cell transplantation (HSCT)
  - id: HP:0012209
    label: Juvenile myelomonocytic leukemia (JMML)
  - id: MAXO:0010203
    label: echocardiography
  - id: HP:0001663
    label: ventricular fibrillation
  - id: HP:0001639
    label: hypertrophic cardiomyopathy
  - id: HP:0032092
    label: left ventricular outflow tract obstruction
  - id: HP:0030828
    label: Wheezing
  - id: CHEBI:90960
    label: Tiotropium
  - id: HP:0002099
    label: bronchial asthma
  - id: MONDO:0007037
    label: Achondroplasia
  - id: MAXO:0000014
    label: radiotherapy
  - id: MAXO:0035118
    label: Cardiac catheterization
  - id: HP:0001659
    label: Aortic regurgitation
  - id: HP:0001004
    label: Lymphedema
  - id: CHEBI:17347
    label: Testosterone
  - id: MONDO:0005516
    label: osteochondrodysplasias
  - id: MONDO:0008300
    label: Prader-Willi syndrome
  - id: MONDO:0000050
    label: Growth Hormone Deficiency (GHD)
  - id: HP:0001510
    label: Poor growth
  - id: MONDO:0007414
    label: Gorham disease
  - id: HP:0012531
    label: Pain
  - id: HP:0010310
    label: Chylothorax
  - id: MONDO:0007893
    label: Noonan syndrome with multiple lentigines
  - id: HP:0001670
    label: asymmetric septal hypertrophy
  - id: MONDO:0011035
    label: Neurofibromatosis-Noonan syndrome
  - id: HP:0000001
    label: acute lymphoblastic leukemia (ALL)
  - id: HP:0000818
    label: endocrinopathies
  - id: HP:0000789
    label: infertility
  - id: MONDO:0019499
    label: Turner syndrome
  - id: MONDO:0006769
    label: Gastroparesis
  - id: MAXO:0000079
    label: Genetic counseling
  - id: HP:0003270
    label: Bloating
  - id: CHEBI:31515
    label: Domperidone
  - id: HP:0002018
    label: nausea
  - id: MAXO:0010032
    label: heart transplantation
  - id: HP:0001635
    label: heart failure
  - id: HP:0031318
    label: myofiber disarray
  - id: CHEBI:68478
    label: everolimus
  - id: MAXO:0001298
    label: therapy
  - id: HP:0003006
    label: neuroblastoma
  - id: MAXO:0025001
    label: cardiac surgery
  - id: HP:0001627
    label: congenital heart disease
  - id: HP:0011675
    label: Arrhythmias
  - id: HP:0002093
    label: Respiratory insufficiency
  - id: HP:0002090
    label: Pneumonia
  - id: HP:0001631
    label: atrial septal defect
  - id: HP:0001999
    label: Dysmorphic facial features
  - id: HP:0000729
    label: Secundum atrial septal defect (ASD)
  - id: HP:0030957
    label: Ventricular septal aneurysm
  - id: HP:0002875
    label: Exertional dyspnea
  - id: HP:0000316
    label: Hypertelorism
  - id: HP:0000914
    label: Shield chest
  - id: HP:0002943
    label: Thoracic scoliosis
  - id: MONDO:0005212
    label: Rhabdomyosarcoma
  - id: HP:0001263
    label: developmental delay
  - id: HP:0005152
    label: congenital cardiomyopathy
  - id: HP:0002027
    label: abdominal pain
  - id: HP:0002019
    label: constipation
  - id: HP:0031500
    label: abdominal mass
  - id: MONDO:0054588
    label: Noonan syndrome-like disorder with loose anagen hair-2 (NSLH2)
  - id: HP:0001252
    label: Hypotonia
  - id: HP:0001249
    label: Intellectual disability
  - id: HP:0011097
    label: epileptic spasms
  - id: MONDO:0021060
    label: RASopathies
  - id: HP:0010816
    label: epidermal nevi
  - id: HP:0010815
    label: nevus sebaceous
  - id: MONDO:0007783
    label: King syndrome
  - id: HP:0002047
    label: malignant hyperthermia
  - id: MONDO:0006664
    label: Atrial Septal Defect
  - id: HP:0003010
    label: prolonged bleeding time
  - id: CHEBI:4450
    label: Desmopressin
  - id: CHEBI:15365
    label: aspirin
  - id: MONDO:0007950
    label: mastocytosis
  - id: MONDO:0019565
    label: von Willebrand disease
  - id: HP:6000310
    label: Preterm premature rupture of membranes
  - id: HP:0002089
    label: Pulmonary hypoplasia
  - id: HP:0001256
    label: Mild mental retardation
  - id: HP:0025676
    label: fetal pleural effusions
  - id: MONDO:0006497
    label: Cerebral Palsy
  - id: MONDO:0002192
    label: Vulvar angiokeratoma
  - id: HP:0030692
    label: brain tumors
  - id: CHEBI:119915
    label: Fentanyl
  - id: CHEBI:6931
    label: Midazolam
  - id: CHEBI:44915
    label: Propofol
  - id: CHEBI:6121
    label: Ketamine
  - id: CHEBI:9130
    label: Sevoflurane
  - id: HP:0002593
    label: intestinal lymphangiectasia
  - id: MAXO:0035035
    label: lymphography
  - id: HP:0002243
    label: protein-losing enteropathy
  - id: HP:0001508
    label: failure to thrive
  - id: CHEBI:8499
    label: propranolol
  - id: CHEBI:135083
    label: cibenzoline
  - id: MONDO:0015280
    label: cardiofaciocutaneous syndrome
  - id: HP:0032152
    label: keratosis pilaris (KP)
  - id: HP:0100837
    label: ulerythema ophryogenes (UO)
  - id: HP:0000972
    label: palmoplantar hyperkeratosis (PPHK)
  - id: CHEBI:50172
    label: acitretin
  - id: CHEBI:9168
    label: sirolimus
  - id: CHEBI:31696
    label: Indocyanine green (ICG)
  - id: MAXO:0000127
    label: Genetic testing
  - id: HP:0001680
    label: aortic coarctation
  - id: MONDO:0019383
    label: Acute Disseminated Encephalomyelitis
  - id: HP:0001945
    label: Fever
  - id: HP:0002329
    label: Drowsiness
  - id: CHEBI:6888
    label: Methylprednisolone
  - id: CHEBI:8382
    label: Prednisone
  - id: CHEBI:27902
    label: Tetracycline
  - id: MAXO:0000004
    label: Surgery
  - id: MAXO:0001610
    label: transcranial magnetic stimulation
  - id: HP:0004415
    label: pulmonary artery stenosis
  - id: MONDO:0009369
    label: Nonimmune hydrops fetalis (NIHF)
  - id: HP:0001790
    label: Nonimmune hydrops fetalis (NIHF)
  - id: CHEBI:40303
    label: Lovastatin
  - id: CHEBI:19226
    label: TMS
  - id: CHEBI:38637
    label: Tyrosine kinase inhibitors
  - id: CHEBI:79091
    label: MEK inhibitors
  - id: HP:0001649
    label: Tachycardia
  - id: HP:0002615
    label: Hypotension
  - id: HP:0032555
    label: Bounding pulses
  - id: HP:0001942
    label: Metabolic acidosis
  - id: CHEBI:6872
    label: Methylene Blue
  - id: CHEBI:18357
    label: Norepinephrine
  - id: CHEBI:18243
    label: Dopamine
  - id: CHEBI:9937
    label: Vasopressin
  - id: MAXO:0000780
    label: Growth hormone (GH) therapy
  - id: MONDO:0005045
    label: Hypertrophic obstructive cardiomyopathy
  - id: HP:0005164
    label: Dysplastic pulmonary valve
  - id: MAXO:0001490
    label: Platelet transfusions
  - id: MONDO:0011331
    label: Congenital chylothorax
  - id: HP:0002202
    label: Pleural effusion
  - id: CHEBI:15904
    label: Long-chain fatty acids (LCFA)
  - id: HP:0000028
    label: cryptorchidism
  - id: HP:0004349
    label: Decreased bone mineral density
  - id: CHEBI:10033
    label: Warfarin
  - id: CHEBI:8093
    label: Phenylephrine
  - id: HP:0002650
    label: scoliosis
  - id: HP:0001655
    label: patent foramen ovale
  - id: HP:0012905
    label: euryblepharon
  - id: HP:0030001
    label: lagophthalmos
  - id: HP:0000271
    label: Facial anomalies
  - id: HP:0001903
    label: anemia
  - id: HP:0010444
    label: Pulmonary incompetence
  - id: MONDO:0015340
    label: DRESS syndrome
  - id: HP:0001880
    label: Eosinophilia
  - id: CHEBI:134975
    label: Fluindione
  - id: CHEBI:50858
    label: Corticosteroids
  - id: CHEBI:53766
    label: Acenocoumarol
  - id: CHEBI:50249
    label: anticoagulant
  - id: MONDO:0017326
    label: Intraduodenal hematoma (IDH)
  - id: HP:0005214
    label: intestinal obstruction
  - id: HP:0002013
    label: vomiting
  - id: HP:0001735
    label: acute pancreatitis
  - id: MONDO:0000565
    label: Infective endocarditis
  - id: HP:0001698
    label: pericardial effusion
  - id: HP:0000969
    label: Hydrops
  - id: MONDO:0006450
    label: Therapy-related Myeloid Neoplasms (t-MN)
  - id: HP:0001873
    label: Thrombocytopenia
  - id: MAXO:0009004
    label: Whole exome sequencing
  - id: HP:0003826
    label: Fetal demise
  - id: HP:0003811
    label: Neonatal death (NND)
  - id: HP:0500092
    label: Orbital rhabdomyosarcoma
  - id: MAXO:0001552
    label: nasotracheal intubation
  - id: HP:0025677
    label: Fetal chylothorax
  - id: MAXO:0001175
    label: Liver Transplantation
  - id: MONDO:0021548
    label: Congenital chylothorax (CCT)
  - id: MAXO:0000503
    label: Mechanical ventilation
  - id: CHEBI:7726
    label: Octreotide
  - id: CHEBI:64628
    label: Somatostatin
  - id: MONDO:0007316
    label: Chiari malformation Type I (CM-I)
  - id: HP:0002878
    label: acute respiratory failure
  - id: HP:0002277
    label: Horner syndrome
  - id: HP:0002094
    label: dyspnea
  - id: MONDO:0006770
    label: Central giant cell granuloma
  - id: HP:0000718
    label: aggressive behavior
  - id: MONDO:0024327
    label: Chronic renal failure
  - id: MONDO:0005030
    label: Intrauterine growth retardation
  - id: MONDO:0007130
    label: Total anomalous pulmonary venous return
  - id: CHEBI:35530
    label: Beta-blocker
